6.29
전일 마감가:
$7.25
열려 있는:
$7.2
하루 거래량:
1.09M
Relative Volume:
1.94
시가총액:
$544.47M
수익:
$14.02M
순이익/손실:
$-84.03M
주가수익비율:
-4.2789
EPS:
-1.47
순현금흐름:
$-125.54M
1주 성능:
-7.78%
1개월 성능:
+10.56%
6개월 성능:
+0.96%
1년 성능:
+25.60%
Meiragtx Holdings Plc Stock (MGTX) Company Profile
명칭
Meiragtx Holdings Plc
전화
646-860-7985
주소
450 EAST 29TH STREET, NEW YORK, NY
MGTX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MGTX
Meiragtx Holdings Plc
|
6.29 | 544.47M | 14.02M | -84.03M | -125.54M | -1.47 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.99 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
606.73 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
653.95 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
271.21 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
255.09 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-31 | 재개 | Chardan Capital Markets | Buy |
2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
2020-09-15 | 재개 | BofA Securities | Buy |
2019-09-03 | 개시 | Piper Jaffray | Overweight |
2019-02-27 | 재확인 | Chardan Capital Markets | Buy |
2018-07-03 | 개시 | Barclays | Overweight |
2018-07-03 | 개시 | BofA/Merrill | Buy |
모두보기
Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스
MeiraGTx Holdings plc's (NASDAQ:MGTX) Shift From Loss To Profit - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Bought by Geode Capital Management LLC - Defense World
Kadmon Announces Sale of 1.4 Million Shares of MeiraGTx Holdings plc - ACCESS Newswire
What is the investor’s view on MeiraGTx Holdings plc (MGTX)? - uspostnews.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by JPMorgan Chase & Co. - Defense World
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - ADVFN
MeiraGTx CFO Richard Giroux sells $144,000 in stock By Investing.com - Investing.com India
MeiraGTx CFO Richard Giroux sells $144,000 in stock - Investing.com
Parkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Russell Investments Group Ltd. Has $1.72 Million Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MGTX Stock Update: MeiraGTx Holdings plc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Corebridge Financial Inc. - Defense World
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 By Investing.com - Investing.com UK
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 - Investing.com
(MGTX) Trading Advice - news.stocktradersdaily.com
MeiraGTx Holdings Signs New Lease in New York - TipRanks
MeiraGTx Holdings secures new lease, terminates old sublease - Investing.com Australia
MeiraGTx Holdings secures new lease, terminates old sublease By Investing.com - Investing.com Canada
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Debt Sensibly? - simplywall.st
MeiraGTx Reports Strategic Advances and Financial Results - TipRanks
Charles Schwab Investment Management Inc. Buys 12,961 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Chardan Capital Forecasts MeiraGTx FY2026 Earnings - MarketBeat
Chardan Capital Comments on MeiraGTx FY2026 Earnings - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Position Increased by Bank of New York Mellon Corp - Defense World
Chardan Capital Forecasts MeiraGTx FY2025 Earnings - Defense World
MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo
Reviewing MeiraGTx (NASDAQ:MGTX) and CRISPR Therapeutics (NASDAQ:CRSP) - Defense World
MeiraGTx (NASDAQ:MGTX) Given New $13.00 Price Target at Royal Bank of Canada - Defense World
MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment - Insider Monkey
Can you still get a good price for MeiraGTx Holdings plc (MGTX) Shares at this point? - uspostnews.com
RBC Capital raises MeiraGTx stock price target to $13.00 By Investing.com - Investing.com Canada
RBC Capital raises MeiraGTx stock price target to $13.00 - Investing.com
RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk - MarketScreener
When the Price of (MGTX) Talks, People Listen - news.stocktradersdaily.com
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume – Here’s Why - Defense World
Top 10 AI News Updates Taking Wall Street By Storm - Insider Monkey
Plaudits For MeiraGTx And Its Parkinson’s AI Pact - insights.citeline.com
US$200M Deal Accelerates Phase 3 Gene Therapy for Parkinsons - Streetwise Reports
MeiraGTx Holdings plc's (NASDAQ:MGTX) 29% Price Boost Is Out Of Tune With Revenues - Simply Wall St
MGTX stock touches 52-week high of $7.9 amid market optimism - Investing.com
MeiraGTx Shares Soar After Joint Venture Deal With Hologen -March 13, 2025 at 03:31 pm EDT - Marketscreener.com
Top Midday Gainers -March 13, 2025 at 02:24 pm EDT - Marketscreener.com
MGTX’s price-to-sales ratio: A comparative analysis with its peers - US Post News
MeiraGTx Holdings plc SEC 10-K Report - TradingView
MeiraGTx earnings beat by $0.08, revenue topped estimates - Investing.com UK
MeiraGTx Collaborates With Hologen AI To Expedite Development Of Parkinson's Candidate, Stock Soars - Benzinga India
Meiragtx Holdings Plc (MGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):